Novothyral
Novothyral is a medicine authorised by Swissmedic under authorisation number 37716. The authorisation holder is Merck (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 01 June 1973 and the authorisation is valid without a time limit. ATC code H03AA03 places the medicine in the group Thyroid therapy.
| Authorisation number | 37716 |
|---|---|
| Name | Novothyral |
| Full name | Novothyral, Tabletten |
| Authorisation holder | Merck (Schweiz) AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | H03AA03 |
| First authorisation | 01 June 1973 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Novothyral, Tabletten | B | 01 June 1973 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 22 | 100 | Tablette(n) | H03AA03 | 07.04.2. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Novothyral authorised in Switzerland?
Yes. Novothyral is authorised by Swissmedic under authorisation number 37716, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Novothyral have?
Novothyral is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Novothyral?
The authorisation holder is Merck (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.